Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Tofacitinib may help regrow hair in alopecia areata patients.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Tigason improved hair growth in a boy with monilethrix without side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

Bazi Bushen capsules reduce skin aging and damage from UV rays.